Hepatitis C viral load and genotypes among Nigerian subjects with chronic infection and implication for patient management: a retrospective review of data.

Journal: The Pan African medical journal
PMID: 33738023

Abstract

INTRODUCTION: Hepatitis C Virus (HCV) is highly infectious with no currently available vaccine. Prior to treatment, it is recommended to confirm HCV infection with either quantitative or qualitative nucleic acid test. Access to these assays in Nigeria is limited but for effective management of patients, HCV viral load (VL) prior to therapy is required and genotype may be needed in some instances. This study aimed at reviewing the pattern of HCV viral load and genotype in the country, and its implication in patient management.

Authors

  • Rosemary Ajuma Audu
    Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Azuka Patrick Okwuraiwe
    Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Fehintola Anthonia Ige
    Center for Human Virology and Genomics, Nigerian Institute of Medical Research, Lagos, Nigeria.
  • Olufunke Oluwatosin Adeleye
    Department of Medicine, College of Medicine, Olabisi Onabanjo University Teaching Hospital, Lagos, Nigeria.
  • Charles Asabamaka Onyekwere
    Department of Medicine, College of Medicine, Lagos State University Teaching Hospital, Lagos, Nigeria.
  • Olufunmilayo Adenike Lesi
    Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.

Keywords

External Resources

Popular Topics
Recent Journals